Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial
Clinical trial NCT05764746 · COMPLETED
Trial details
- NCT number
- NCT05764746
- Sponsor
- Muhimbili University of Health and Allied Sciences
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-01
- Primary completion
- 2024-12-30
- Enrollment
- 384
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.